Arrowhead Pharmaceuticals, Inc.

8-K Director or officer change Jun 16, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Shareholder vote results Mar 20, 2026 10-Q Quarter ended 2025-12-31 Feb 5, 2026 8-K Results of operations (earnings release) Feb 5, 2026 8-K Entered a material agreement; Took on a direct financial obligation Jan 12, 2026 8-K Entered a material agreement; Other events Jan 9, 2026 8-K Regulation FD disclosure; Other events Jan 6, 2026 10-K Fiscal year ended 2025-09-30 Nov 25, 2025 8-K Results of operations (earnings release) Nov 25, 2025 8-K Other events Nov 18, 2025 10-K/A Fiscal year ended 2024-09-30 Oct 10, 2025 8-K Other events Sep 12, 2025 8-K Other events Sep 11, 2025 8-K Entered a material agreement Sep 2, 2025 8-K Results of operations (earnings release) Aug 7, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) May 12, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Director or officer change Apr 15, 2025 8-K Shareholder vote results Mar 19, 2025 8-K Results of operations (earnings release) Feb 10, 2025 10-Q Quarter ended 2024-12-31 Feb 10, 2025 8-K Director or officer change Feb 7, 2025 8-K Director or officer change Dec 18, 2024 8-K Results of operations (earnings release) Nov 26, 2024 10-K Fiscal year ended 2024-09-30 Nov 26, 2024 8-K Results of operations (earnings release) Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) May 9, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Shareholder vote results Mar 19, 2024 8-K/A Director or officer change Mar 18, 2024 8-K Director or officer change Feb 22, 2024 10-Q Quarter ended 2023-12-31 Feb 6, 2024 8-K Results of operations (earnings release) Feb 6, 2024 8-K Director or officer change Jan 22, 2024 8-K Entered a material agreement Jan 4, 2024 8-K Changed accountants Dec 5, 2023